Antimicrobial Resistance Surveillance Market Analysis Highlighting Growth Potential
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Antimicrobial Resistance Surveillance Market During The Forecast Period?
The antimicrobial resistance surveillance market size has experienced robust growth in recent years. It is forecast to increase from $7.3 billion in 2025 to $7.91 billion in 2026, with a compound annual growth rate (CAGR) of 8.4%. The expansion observed in the past can be attributed to factors such as the rise in drug-resistant infections, hospital infection control initiatives, public health surveillance programs, laboratory testing expansion, and antibiotic misuse concerns.
The antimicrobial resistance surveillance market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $10.85 billion, exhibiting a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast timeframe is largely due to worldwide initiatives for monitoring AMR, predictive surveillance powered by AI, data sharing facilitated by cloud technology, an increase in genomic surveillance, and reporting mandates driven by policy. Key trends observed within this period encompass real-time tracking of resistance patterns, surveillance utilizing whole genome sequencing, analytics of resistance powered by artificial intelligence, unified public health databases, and comprehensive hospital-wide systems for AMR tracking.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
What Key Factors Are Affecting The Antimicrobial Resistance Surveillance Market Demand?
The expanding occurrence of infectious diseases is set to drive the growth of the antimicrobial resistance surveillance market in the future. These illnesses originate from harmful microorganisms like bacteria, viruses, fungi, or parasites and can spread either directly or indirectly among individuals. The escalating prevalence of infectious diseases is linked to factors such as climate change, urbanization, and global travel, which collectively boost the spread of pathogens and human exposure to new microbes. Antimicrobial resistance surveillance is vital for tracking the dissemination of resistant pathogens, guiding effective treatment approaches, and shaping public health policies to combat these diseases. For instance, in February 2024, a report from the UK Health Security Agency, a UK-based government body, indicated that tuberculosis (TB) cases in England surged by 10.7% in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Thus, the growing prevalence of infectious diseases is a significant catalyst for the expansion of the antimicrobial resistance surveillance market.
Which Segments Define The Antimicrobial Resistance Surveillance Market Segment Structure?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
What Trends Are Influencing Changes In The Antimicrobial Resistance Surveillance Market?
Leading companies in the market are concentrating on advanced technologies, particularly innovative diagnostic instruments, to optimize operations, boost effectiveness, enhance precision, lower expenditures, and achieve superior outcomes for patients and end-users. A diagnostic tool is defined as any device, apparatus, software, or approach utilized to identify, detect, or evaluate the presence of a specific condition, illness, malfunction, or problem. For example, in June 2023, Sysmex Astrego AB, a manufacturer and service provider of diagnostic products based in Sweden, announced the introduction of its PA-100 AST Point-of-Care Testing System. This system allows for swift and accurate detection of antimicrobial resistance directly at the point of care, providing a notable time saving when compared to conventional laboratory techniques, which often require up to several days. By yielding results in just 30 minutes, it enables clinicians to make prompt and informed decisions concerning suitable treatments for infections, thereby decreasing reliance on broad-spectrum antibiotics and assisting in the effort to control the dissemination of antimicrobial resistance.
Who Are The Established Players Within The Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.
Get The Full Antimicrobial Resistance Surveillance Market Report:
Which Region Represents The Largest Share Of The Antimicrobial Resistance Surveillance Market?
North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antimicrobial Resistance Surveillance Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance Surveillance Market 2026, By The Business Research Company
Pediatric Orthopedic Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report
Orthopedic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report
Orthopedic Regenerative Surgical Products Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
